Skip to content
ProGenis Pharmaceuticals Group

Our Story

ProGenis Pharmaceuticals is a leading RNA biotechnology company, founded in Perth, Western Australia, in 2022. We are dedicated to developing next-generation, precision RNA medicines for the treatment of acquired and inherited rare diseases.

Co-founded by renowned experts Professor Marvin Caruthers and Associate Professor Rakesh Veedu, our team is driven by a shared commitment to improving the health and wellbeing of individuals through groundbreaking therapeutics.

We are driven by innovation

We are dedicated to developing breakthrough, disease-modifying therapeutics that are safer, more effective, and accessible, offering new hope to patients suffering from chronic and debilitating conditions.

Driven by Innovation
Safe

Safe

No or low off-target toxicity

Effective

Effective

Precisely targeting the gene hallmark

Accessible

Accessible

Affordable costs for all patients

Board Members

Our board members and advisory board are seasoned experts in biotechnology, medicine, and business, providing strategic leadership to drive ProGenis Pharmaceuticals’ mission of developing innovative RNA therapeutics.

Marvin H. Caruthers

Prof. Marvin H. Caruthers

Co-Founder & Director Board Member

Rakesh N Veedu

Assoc. Prof. Rakesh N. Veedu

Co-Founder & Director Board Member

Sudhir Agrawal

Dr. Sudhir Agrawal

Scientific Advisor

Bu Yeap

Prof. Bu Yeap

Clinical Advisor

Girish Dwivedi

Prof. Girish Dwivedi

Clinical Advisor